Carole Ho

What if we could identify who would respond to a new medicine before starting treatment?

Apply to Attend TEDMED 2018
Join us in Palm Springs, CA at The La
Quinta Resort and Club, this Nov 14 - 16, 2018.
Apply Today!

Have a suggestion for The Hive?
Submit a Nomination Today

Share This Talk

About Carole Ho

Carole Ho is the Chief Medical Officer of Denali Therapeutics. Carole’s curiosity of how the brain functions in health and disease guided her career from clinical neurologist to bench neuroscientist at Harvard and Stanford, after which she moved on to Genentech as an industry drug developer. She has a passion for innovative approaches to tailoring therapies for those that are most likely to respond. She has provided leadership for a landmark prevention trial in familial inherited Alzheimer's Disease in an extended Colombian family and has successfully translated genetic discoveries to therapies in the clinic at Genentech. 

About This Idea

Neurodegenerative diseases are the largest medical challenges of our time, and Denali Therapeutics is dedicated to defeating them through rigorous therapeutic discovery and development. Denali is founded on the collaboration of leading scientists, industry experts and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients. Recent groundbreaking scientific insights into the genetic causes and biological processes underlying neurodegenerative diseases offer an unprecedented opportunity for the discovery and development of effective medicines for Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases.

Other Hive Talks